4/A//SEC Filing
Giles Mark T 4/A
Accession 0001437749-19-015540
CIK 0001053691other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 8:53 AM ET
Size
6.9 KB
Accession
0001437749-19-015540
Insider Transaction Report
Form 4/AAmended
Giles Mark T
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-13+19,200→ 19,200 totalExercise: $3.15Exp: 2029-06-13→ Common Stock (19,200 underlying)
Holdings
- 294(indirect: By IRA)
Common Stock
- 53,513(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001663219
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 8:53 AM ET
- Size
- 6.9 KB